A study led by researchers in the University of Florida College of Pharmacy has found that GLP-1RA drugs, a class of ...
Researchers say they have uncovered a link between semaglutide — the active ingredient in Ozempic and Wegovy — and sudden vision loss. The risk of developing non-arteritic anterior ischemic ...
Authors of a new study say additional research is needed to determine causality between semaglutide and a condition called NAION Mario Tama/Getty People who take Ozempic and Wegovy may have a ...
New research released on Wednesday suggests that Ozempic and similar medications may have unexpected side effects. Doctors in Massachusetts have found a link between the drug’s active ingredient ...
I’m not a crier. I could count on two hands the number of times I’d cried as an adult – but that all changed in 2024. I’ve spent hours of every day lying on the floor, screaming and in ...
We include products we think are useful for our readers. If you buy through links on this page, we may earn a small commission. Here’s our process. Wegovy is a weight loss medication that you ...
People who were overweight or obese and prescribed the drugs were more than seven times as likely to develop the condition as those on other weight-loss medicines (Alamy/PA) Meanwhile, people who ...
Semaglutide, the active ingredient in weight-loss medications Ozempic and Wegovy, may be associated with an increased risk of an eye condition that causes vision loss, a new study suggests.
Patients who took the frequently prescribed diabetes and weight-loss drugs Ozempic and Wegovy faced a greater risk of a stroke of the optic nerve, which can lead to blindness, according to a new ...